Trial intelligence / Profile preview

DISCO: DIScontinuation of COncomitant DMARDs in RA Patients Using TNF Inhibitors

NCT07802678Phase 4Recruiting

Sponsor
Sint Maartenskliniek
Start
Jul 2026
Primary completion
May 2029
Countries
1
01

Overview

A Phase 4 trial of methotrexate, leflunomide in rheumatoid arthritis (RA), sponsored by Sint Maartenskliniek. Started Jul 2026; status: recruiting.

02

Drugs

methotrexateleflunomide
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT07802678.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07802678.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call